MarketPeel
Insider Trading Intelligence
Pricing
…
CD

Charles Cliff Duncan

VNDA
DIRECTOR · VANDA PHARMACEUTICALS INC. · CIK 0002130896
FILING MIX · LIFETIME100%/0%
BUYS
2
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Apr 2026
HOLDINGS NOW
98,701
AVG SELL PX
—
TRADE KIND
SHOWING 2 / 2
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Charles Cliff Duncan. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
VNDA · 98,701 shares · as of Jun 4, 2026
024,67549,35174,02698,701SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2026
FLOW · 2 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
41,600——98,701Jun 4, 2026Jun 8, 2026 ↗View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
57,101——57,101Apr 22, 2026Apr 24, 2026 ↗View →
Other insiders · VNDA
Loading peer insiders…
About this filer
CIK 0002130896
ROLE
Director
PRIMARY
VNDA
COMPANIES
1
ACTIVE SINCE
Apr 2026
MARKETPEEL · /INSIDER/0002130896DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback